APA (7th ed.) Citation

Padilla-Padilla, F. G., Ruiz-Bernes, L. N., Román-Pintos, L. M., Peraza-Zaldívar, J. A., Sander-Padilla, J. G., Lugo-Sánchez, L. A., . . . González-Canudas, J. (2025). Efficacy and Safety of the Fixed-Dose Combination of Atorvastatin/Fenofibrate Versus Atorvastatin on the Lipid Profile of Patients with Type 2 Diabetes and Dyslipidemia. Cardiology and Therapy, 14(2), 297-314. https://doi.org/10.1007/s40119-025-00410-y

Chicago Style (17th ed.) Citation

Padilla-Padilla, Francisco G., et al. "Efficacy and Safety of the Fixed-Dose Combination of Atorvastatin/Fenofibrate Versus Atorvastatin on the Lipid Profile of Patients with Type 2 Diabetes and Dyslipidemia." Cardiology and Therapy 14, no. 2 (2025): 297-314. https://doi.org/10.1007/s40119-025-00410-y.

MLA (9th ed.) Citation

Padilla-Padilla, Francisco G., et al. "Efficacy and Safety of the Fixed-Dose Combination of Atorvastatin/Fenofibrate Versus Atorvastatin on the Lipid Profile of Patients with Type 2 Diabetes and Dyslipidemia." Cardiology and Therapy, vol. 14, no. 2, 2025, pp. 297-314, https://doi.org/10.1007/s40119-025-00410-y.